Hospital
Parkview Medical Center, INC.
Parkview Medical Center, INC. was paid $20.72M by Medicaid between Jan 2018 and Dec 2024, across 128 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoPARKVIEW MEDICAL CENTER, INC.
PUEBLO, CO 81003
PUEBLO, CO 81003
33aNPI1104881507assigned 04/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.72M
24GClaims618,733
24DCodes billed128
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#9 of 51
Median peer was paid$1.24M
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 102,587 | $3.11M | |
| 2019 | 94,799 | $2.97M | |
| 2020 | 73,380 | $2.15M | |
| 2021 | 95,087 | $2.72M | |
| 2022 | 107,124 | $3.76M | |
| 2023 | 75,117 | $3.14M | |
| 2024incomplete | 70,639 | $2.87M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 74,216 | 70,548 | $6.85M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 52,467 | 49,431 | $4.87M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 36,706 | 34,184 | $3.52M |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.0% | 6,466 | 6,041 | $1.44M |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.6% | 49,046 | 45,380 | $542K |
| 80053 | Comprehensive metabolic panel | 2.5% | 33,697 | 31,586 | $524K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.9% | 1,778 | 1,657 | $403K |
| 64483 | 1.5% | 612 | 531 | $318K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 2,008 | 1,848 | $251K |
| 64493 | <1% | 508 | 415 | $174K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 2,808 | 2,696 | $174K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 6,245 | 1,981 | $125K |
116 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,237 | $112K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,115 | $107K |
| 73630 | <1% | 2,490 | $106K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 250 | $100K |
| 43235 | <1% | 365 | $95K | |
| 84484 | <1% | 6,864 | $90K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 261 | $81K |
| 80320 | <1% | 906 | $68K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 366 | $63K |
| G0378 | Hospital observation service, per hour | <1% | 311 | $46K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 740 | $42K |
| 73610 | <1% | 1,028 | $37K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 422 | $31K |
| 62321 | <1% | 89 | $31K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 155 | $29K |
| 59025 | Fetal non-stress test | <1% | 229 | $28K |
| 72110 | <1% | 451 | $26K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 182 | $26K |
| 77386 | <1% | 164 | $26K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 82 | $26K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 32,318 | $21K |
| 77336 | <1% | 494 | $20K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 74 | $19K |
| 95819 | <1% | 128 | $18K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,489 | $18K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 971 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 91,983 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 16,166 | $15K |
| 50590 | <1% | 12 | $15K | |
| 81003 | <1% | 30,148 | $14K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 168 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 72 | $13K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 36,530 | $12K |
| 72052 | <1% | 159 | $12K | |
| 72114 | <1% | 210 | $11K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 834 | $10K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 167 | $8K |
| 71250 | <1% | 139 | $8K | |
| 64490 | <1% | 13 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,924 | $7K |
| 94060 | <1% | 85 | $5K | |
| 97161 | <1% | 43 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 10,575 | $5K |
| 77338 | <1% | 53 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $5K |
| 62323 | <1% | 14 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,334 | $4K |
| 77470 | <1% | 15 | $4K | |
| 74018 | <1% | 60 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 26 | $3K |
| 11043 | <1% | 18 | $3K | |
| 83690 | <1% | 13,336 | $3K | |
| 77300 | <1% | 65 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 28 | $2K |
| 94729 | <1% | 83 | $2K | |
| 94726 | <1% | 79 | $2K | |
| 87420 | <1% | 42 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 18,253 | $2K |
| 73130 | <1% | 25 | $2K | |
| 82077 | <1% | 1,309 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,667 | $1K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 74 | $1K |
| 81025 | <1% | 1,646 | $1K | |
| 64494 | <1% | 562 | $804.93 | |
| 87581 | <1% | 29 | $580.25 | |
| 80076 | <1% | 169 | $550.42 | |
| 83735 | <1% | 2,400 | $448.51 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 85 | $327.12 |
| 36415 | Collection of venous blood by venipuncture | <1% | 439 | $248.53 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,189 | $234.68 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 600 | $231.29 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,843 | $230.49 |
| 81001 | <1% | 4,727 | $202.35 | |
| 88312 | <1% | 1,182 | $168.31 | |
| 82805 | <1% | 13 | $167.79 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 41 | $159.28 |
| 84145 | <1% | 46 | $155.04 | |
| 85379 | <1% | 28 | $150.64 | |
| 87486 | <1% | 29 | $145.09 | |
| 64495 | <1% | 451 | $114.58 | |
| 85610 | <1% | 138 | $93.24 | |
| 84703 | <1% | 1,530 | $79.75 | |
| 85730 | <1% | 26 | $45.12 | |
| 85027 | <1% | 13 | $22.04 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 179 | $16.52 |
| J3490 | Unclassified drugs | <1% | 14,868 | $7.80 |
| 82947 | <1% | 416 | $7.41 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,426 | $5.84 |
| J2704 | Injection, propofol, 10 mg | 0% | 8,011 | $0.00 |
| 87081 | 0% | 90 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,725 | $0.00 |
| 64484 | 0% | 31 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 346 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 12 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 485 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 237 | $0.00 |
| 82962 | 0% | 256 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 95 | $0.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 0% | 13 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 28 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 13 | $0.00 |
| 84436 | 0% | 14 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 3,072 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 2,128 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 461 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 1,409 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 64 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 4,274 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 171 | $0.00 |
| 84100 | 0% | 37 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 77 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 85 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 13 | $0.00 |
| 93017 | 0% | 13 | $0.00 | |
| 64491 | 0% | 24 | $0.00 | |
| 84439 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIGGS, JON (CFO)
| Provider | Location | Paid |
|---|---|---|
| Parkview Medical Center, INC. | Pueblo, CO | $14.21M |
| Parkview Medical Center, INC. | Pueblo West, CO | $3.26M |
| Parkview Medical Center, INC. | Pueblo, CO | $1.06M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.